Semaglutide and Bone Fracture Risk: What People With Type 2 Diabetes Should Know 24th September 202624th June 2026 by Living Diabetes Editorial An ENDO 2026 real-world study linked semaglutide with fewer bone fractures than several other weight-loss medicines in adults with type 2 diabetes. The finding is interesting, but it does not prove semaglutide prevents fractures.
Amycretin: What to Know About This Investigational GLP-1 and Amylin Medicine 6th June 20266th April 2026 by Living Diabetes Editorial Team Amycretin is an investigational GLP-1 and amylin medicine. Learn what early studies show, what is still unknown, and safety caveats.
